Provention Bio Investor Relations Material

Provention Bio Inc. is a biopharmaceutical company focused on the development of therapies aimed at preventing and intercepting immune-mediated diseases, particularly in areas with significant unmet medical needs. The company specializes in immunology, working to create treatments that modulate the immune system to prevent the onset or progression of chronic diseases. Provention Bio collaborates with healthcare providers and research institutions to bring innovative therapeutic options to patients at risk of developing conditions with autoimmune components. The company is headquartered in Red Bank, New Jersey, and its shares are listed on the NASDAQ.